Pelgran Pharma

Hyderabad, India Founded: 2013 • Age: 13 yrs
Manufactures high-quality pharmaceutical pellets for medical applications.

About Pelgran Pharma

Pelgran Pharma was a Healthcare company based in Hyderabad (India) founded in 2013. It manufactures high-quality pharmaceutical pellets for medical applications. It operates on a B2B model. Its Indian entity Pelgran Pharma Private Limited reported revenue of β‚Ή36.1 Lakh. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Drug Manufacturing and Pellet Production. Its competitors include Inventia Healthcare, Zim Labs and Halewood Laboratories; 2 of its 3 listed competitors have raised funding.

Company details

Pelgran Pharma, established in 2013 and currently in Dissolved stage, focuses on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and pellet production. Manufactures high-quality pharmaceutical pellets for medical applications. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.

Key Metrics
  • Annual Revenue
    ₹36.1 Lakh

    FY 2024 · -29% YoY

  • Net Loss
    -₹65.8 Lakh

    FY 2024 · -182% margin

  • EBITDA
    -₹40.3 Lakh

    FY 2024 · -112% margin

Board of directors of Pelgran Pharma Private Limited (Pelgran Pharma)

Pelgran Pharma Private Limited is the primary company behind Pelgran Pharma. The board of Pelgran Pharma Private Limited currently have 5 directors; the longest-serving is Pavani Prasad Undavalli, appointed in 2013. 4 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Pavani Prasad Undavalli
DIN 00286108
Director12 Jun 201313 yrs 4 moPelgran Pharma Private Limited
Rajesh Alla
DIN 06507929
Director12 Jun 201313 yrs 4 moPelgran Pharma Private Limited
Laxminarayana Reddy Darakapalli
DIN 08038979
Director01 Apr 20197 yrs 6 moPelgran Pharma Private Limited
Purnima Rajesh Alla
DIN 00278772
Director02 Sep 20197 yrs 1 moPelgran Pharma Private Limited
Bharatha Lakhsmi Vadlamudi
DIN 02156795
Director08 Jun 20206 yrs 4 moPelgran Pharma Private Limited

Financials of Pelgran Pharma

Figures of Pelgran Pharma Private Limited, the primary company behind Pelgran Pharma, for FY 2024. Revenue was ₹36.1 Lakh (-29% year on year). Net loss was -₹65.8 Lakh (-182% margin). EBITDA was -₹40.3 Lakh (-112% margin). Revenue has grown at a compounded annual rate of -43% over three years and -30% over five years.

  • ₹36.1 LakhRevenue · FY 2024 · -29% YoY
  • -₹65.8 LakhNet loss · -182% margin
  • -₹40.3 LakhEBITDA · -112% margin
  • ₹1.59 CrPaid-up capital
  • -43%Revenue CAGR, 3 years
  • -30%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Pelgran Pharma Private Limited are on its company page.

Premium access

Detailed financial statements for Pelgran Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of Pelgran Pharma

Pelgran Pharma has 3 listed competitors in our database, 2 of them funded. They include Inventia Healthcare, Zim Labs and Halewood Laboratories.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
inventiahealthcare.com1985Mumbai, India$42.49M980
Oral solid drug delivery systems are manufactured and developed.
zimlab.in1989Nagpur, India$8.2M598
Solid and semisolid dosage forms are developed and manufactured.
halewoodlabs.com1984Ahmedabad, India348
Provides contract manufacturing services for food, pharmaceuticals, and related products globally.
Premium access

Detailed competitors of Pelgran Pharma

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Pelgran Pharma

Pelgran Pharma was founded in 2013.

Pelgran Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

The primary company behind Pelgran Pharma, Pelgran Pharma Private Limited, reported revenue of β‚Ή36.1 Lakh for FY 2024, down 29% year on year.

Pelgran Pharma, established in 2013 and currently in Dissolved stage, focuses on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and pellet production. Manufactures high-quality pharmaceutical pellets for medical applications. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.

Pelgran Pharma's top competitors include Inventia Healthcare, Zim Labs and Halewood Laboratories.

Pelgran Pharma operates through Pelgran Pharma Private Limited.

The legal entities of Pelgran Pharma currently have 5 directors, including Pavani Prasad Undavalli, Purnima Rajesh Alla, Bharatha Lakhsmi Vadlamudi and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available